Tobias Stemler

579 total citations
15 papers, 413 citations indexed

About

Tobias Stemler is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tobias Stemler has authored 15 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Tobias Stemler's work include Radiopharmaceutical Chemistry and Applications (12 papers), Prostate Cancer Treatment and Research (8 papers) and Peptidase Inhibition and Analysis (5 papers). Tobias Stemler is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Prostate Cancer Treatment and Research (8 papers) and Peptidase Inhibition and Analysis (5 papers). Tobias Stemler collaborates with scholars based in Germany and Switzerland. Tobias Stemler's co-authors include Samer Ezziddin, Mark Bartholomä, Stephan Maus, Florian Rosar, Fadi Khreish, Johannes Linxweiler, Matthias Saar, Martin Ries, Andrea Schaefer-Schuler and Jonas Krause and has published in prestigious journals such as Theranostics, Synthesis and Organic & Biomolecular Chemistry.

In The Last Decade

Tobias Stemler

15 papers receiving 406 citations

Peers

Tobias Stemler

RNMI

PRM

ONCOL

SPECT

Yvonne Remde Germany

Johncy Mahapane South Africa

Florette Reyneke South Africa

Stefan Wiessalla Germany

Christian H. Pfob Germany

Martina Wirtz Germany

Donika Plyku United States

Leon Will Germany

Viviane J. Tschan Switzerland

Otto Knoesen South Africa

Yvonne Remde Germany

Tobias Stemler

364 ×1.0

RNMI

341 ×1.1

PRM

137 ×1.0

ONCOL

32 ×0.8

SPECT

42 ×1.2

Citations per year, relative to Tobias Stemler Tobias Stemler (= 1×) peers Yvonne Remde

Countries citing papers authored by Tobias Stemler

Since Specialization

Citations

This map shows the geographic impact of Tobias Stemler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Stemler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Stemler more than expected).

Fields of papers citing papers by Tobias Stemler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Stemler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Stemler. The network helps show where Tobias Stemler may publish in the future.

Co-authorship network of co-authors of Tobias Stemler

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Stemler. A scholar is included among the top collaborators of Tobias Stemler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Stemler. Tobias Stemler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Schaefer-Schuler, Andrea, Caroline Burgard, Stephan Maus, et al.. (2024). [¹⁶¹Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [¹⁷⁷Lu]Lu-PSMA-617. Theranostics. 14(5). 1829–1840. 22 indexed citations

Stemler, Tobias, Florian Rosar, Caroline Burgard, et al.. (2024). Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform. EJNMMI Radiopharmacy and Chemistry. 9(1). 84–84. 2 indexed citations

Burgard, Caroline, Tobias Stemler, Stephan Maus, et al.. (2023). Radiometal Complexes as Pharmacokinetic Modifiers: A Potent ⁶⁸Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me. Molecular Pharmaceutics. 20(12). 6463–6473. 1 indexed citations

Stemler, Tobias, et al.. (2022). Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform. Nuclear Medicine and Biology. 108-109. S41–S41. 1 indexed citations

Rosar, Florian, Mark Bartholomä, Tobias Stemler, et al.. (2021). Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy. EJNMMI Physics. 8(1). 40–40. 32 indexed citations

Rosar, Florian, Mark Bartholomä, Stephan Maus, et al.. (2021). Molecular imaging and biochemical response assessment after a single cycle of [²²⁵Ac]Ac-PSMA-617/[¹⁷⁷Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [¹⁷⁷Lu]Lu-PSMA-617 monotherapy. Theranostics. 11(9). 4050–4060. 60 indexed citations

Rosar, Florian, Jonas Krause, Mark Bartholomä, et al.. (2021). Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis. Pharmaceutics. 13(5). 722–722. 44 indexed citations

Stemler, Tobias, Caroline Hoffmann, Stephan Maus, et al.. (2021). A Structure‐Activity Relationship Study of Bimodal BODIPY‐Labeled PSMA‐Targeting Bioconjugates. ChemMedChem. 16(16). 2535–2545. 10 indexed citations

Rosar, Florian, Mark Bartholomä, Stephan Maus, et al.. (2021). Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function. Cancers. 13(12). 3095–3095. 32 indexed citations

10.

Khreish, Fadi, Mark Bartholomä, Stephan Maus, et al.. (2021). Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT. Cancers. 13(16). 4134–4134. 25 indexed citations

11.

Maus, Stephan, Tobias Stemler, Florian Rosar, et al.. (2020). Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates. Molecular Imaging and Biology. 23(1). 95–108. 7 indexed citations

12.

Khreish, Fadi, M. Ries, Stephan Maus, et al.. (2020). 225 Ac-PSMA-617/ 177 Lu-PSMA-617 Tandem Therapy of Metastatic Castration-Resistant Prostate Cancer: Pilot Experience. Nuklearmedizin - NuclearMedicine. 8 indexed citations

13.

Khreish, Fadi, Martin Ries, Stephan Maus, et al.. (2019). 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience. European Journal of Nuclear Medicine and Molecular Imaging. 47(3). 721–728. 151 indexed citations

14.

Holland, Jason P., Tilman Läppchen, Harald Scherer, et al.. (2018). Optimized synthesis and indium complex formation with the bifunctional chelator NODIA-Me. Organic & Biomolecular Chemistry. 16(40). 7503–7512. 15 indexed citations

15.

Trommer, Wolfgang E., et al.. (2014). Synthesis of Novel Fluorescent Stilbenenitrones via a Mild, Ligand-Free Heck-Type Reaction of (E)-[4-(1,3-Dioxolan-2-yl)styryl]trimethylsilane with Benzene Diazonium Tetrafluoroborate Derivatives. Synthesis. 46(22). 3103–3109. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact